Kidney Transplant
211
40
49
98
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
33 trials with published results (16%)
Research Maturity
98 completed trials (46% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.6%
16 terminated out of 211 trials
86.0%
-0.6% vs benchmark
24%
50 trials in Phase 3/4
34%
33 of 98 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 98 completed trials
Clinical Trials (211)
GraftAssure Lowering Allograft rejeCTIon by Combination- (GALACTIC) Trial
Immunosuppression Optimization Using The Prospera Assay In Kidney Transplant Recipients (IMPAKT)
Prediction and Prevention of Bloodstream Infections After Kidney Transplantation
Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma
Letermovir for R+ Study
Remote vs In-Person Prehabilitation for Kidney Transplant Candidates
Development and Validation of HistoMX, a Gene-Expression Platform for Molecular Interpretation of Kidney Allograft Biopsies
Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation
Comparison of the Effects of General Anesthesia and Combined Spinal-Epidural Anesthesia on Ferroptosis, Humanin and MOTS-c Levels in Renal Transplantation
Feasibility and Plausible Effectiveness of a Lifestyle Intervention in Kidney Transplant Recipients (HEAL)
Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients
Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis
Alloreactive Memory B Lymphocytes and Anti-HLA Sensitization
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
Impact of Culture of Perfusion Fluid on Donor-derived Infection Management and Outcome in Liver and Kidney Transplant
Phenotype Guided Vasoactive Medication During Kidney Transplantation
Risk Factors Associated With the Absence of CMV-specific Cellular Immune Response in the Early Post-transplant Period in Low-risk CMV-seropositive Kidney Transplant Recipients
CAR-T Cell Therapy for Desensitization in Kidney Transplantation
Perceptions of Kidney Transplant Recipients Regarding the Role of Artificial Intelligence in Medicine
Advancing Transplantation Outcomes in Children